The global market for Antimicrobial Susceptibility Testing is estimated at US$3.6 Billion in 2023 and is projected to reach US$4.6 Billion by 2030, growing at a CAGR of 3.5% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the antimicrobial susceptibility testing market is driven by several factors. The increasing prevalence of antibiotic-resistant infections is a primary driver, necessitating more frequent and comprehensive testing. Government initiatives and regulations aimed at controlling the spread of resistance and improving antibiotic use are also contributing to market growth. Additionally, the growing demand for rapid and accurate diagnostic tools in healthcare settings has spurred the adoption of advanced AST methods. The expansion of clinical laboratories and the rising investment in research and development further support the market. These factors, combined with the ongoing need for effective infection control measures, ensure a strong growth trajectory for the antimicrobial susceptibility testing market.
The growth in the antimicrobial susceptibility testing market is driven by several factors. The increasing prevalence of antibiotic-resistant infections is a primary driver, necessitating more frequent and comprehensive testing. Government initiatives and regulations aimed at controlling the spread of resistance and improving antibiotic use are also contributing to market growth. Additionally, the growing demand for rapid and accurate diagnostic tools in healthcare settings has spurred the adoption of advanced AST methods. The expansion of clinical laboratories and the rising investment in research and development further support the market. These factors, combined with the ongoing need for effective infection control measures, ensure a strong growth trajectory for the antimicrobial susceptibility testing market.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Manual Antimicrobial Susceptibility Testing Products segment, which is expected to reach US$1.5 Billion by 2030 with a CAGR of a 3.7%. The Automated Laboratory Instruments segment is also set to grow at 3.0% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $970.2 Million in 2023, and China, forecasted to grow at an impressive 6.8% CAGR to reach $992.2 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Antimicrobial Susceptibility Testing Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Antimicrobial Susceptibility Testing Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Antimicrobial Susceptibility Testing Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Accelerate Diagnostics, Inc., Alifax S.r.l., Becton Dickinson, and Company, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 52 Featured):
- Accelerate Diagnostics, Inc.
- Alifax S.r.l.
- Becton Dickinson, and Company
- bioMérieux SA
- Bio-Rad Laboratories, Inc.
- Biotron Limited
- Bruker Corp.
- Creative Diagnostics
- Danaher Corporation
- ELITech Group
- F. Hoffmann-La Roche AG
- HiMedia Laboratories Pvt. Ltd.
- Liofilchem S.r.l.
- Mast Group Ltd.
- Merck KGaA
- MP Biomedicals LLC
- Q-linea AB
- QuantaMatrix, Inc.
- Resistell AG
- Thermo Fisher Scientific, Inc.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Accelerate Diagnostics, Inc.
- Alifax S.r.l.
- Becton Dickinson, and Company
- bioMérieux SA
- Bio-Rad Laboratories, Inc.
- Biotron Limited
- Bruker Corp.
- Creative Diagnostics
- Danaher Corporation
- ELITech Group
- F. Hoffmann-La Roche AG
- HiMedia Laboratories Pvt. Ltd.
- Liofilchem S.r.l.
- Mast Group Ltd.
- Merck KGaA
- MP Biomedicals LLC
- Q-linea AB
- QuantaMatrix, Inc.
- Resistell AG
- Thermo Fisher Scientific, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 382 |
| Published | July 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 3.6 Billion |
| Forecasted Market Value ( USD | $ 4.6 Billion |
| Compound Annual Growth Rate | 3.5% |
| Regions Covered | Global |
